JSMGX
Price
$31.19
Change
-$0.43 (-1.36%)
Updated
Aug 20 closing price
Net Assets
5.66B
NRGSX
Price
$62.63
Change
+$0.26 (+0.42%)
Updated
Aug 21 closing price
Net Assets
7.39B
Interact to see
Advertisement

JSMGX vs NRGSX

JSMGX vs NRGSX Comparison Chart in %
View a ticker or compare two or three
VS
JSMGX vs. NRGSX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSMGX is a Buy and NRGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NRGSX has more cash in the bank: 7.39B vs. JSMGX (5.67B). NRGSX pays higher dividends than JSMGX: NRGSX (0.45) vs JSMGX (0.00). JSMGX was incepted earlier than NRGSX: JSMGX (17 years) vs NRGSX (13 years). JSMGX (0.78) is less costly to investors than NRGSX (0.74). NRGSX is a more actively managed with annual turnover of: 23.00 vs. JSMGX (20.00). NRGSX has a lower initial minimum investment than JSMGX: NRGSX (0) vs JSMGX (1000000). JSMGX annual gain was more profitable for investors over the last year : 11.99 vs. NRGSX (-1.20). NRGSX return over 5 years is better than : -18.93 vs. JSMGX (-21.65).
JSMGXNRGSXJSMGX / NRGSX
Total Expense Ratio0.780.74105%
Annual Report Gross Expense Ratio0.780.74105%
Fund Existence17 years13 years-
Gain YTD16.42416.54399%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.67B7.39B77%
Annual Yield % from dividends0.000.45-
Returns for 1 year11.99-1.20-998%
Returns for 3 years19.507.14273%
Returns for 5 years-21.65-18.93114%
Returns for 10 years27.3112.86212%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEPG3.140.10
+3.46%
PepGen
TPST1.040.02
+1.96%
Tempest Therapeutics Inc
ACAD29.500.46
+1.58%
ACADIA Pharmaceuticals
RELX35.910.53
+1.50%
Relx PLC
AVTX19.830.01
+0.05%
Avalo Therapeutics